Clinical Trials Browser

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT00875849 2025-09-30

AACER

Phase 2 Completed

53 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT01982448 2025-09-30

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

Phase 2 Completed

147 enrolled 15 charts

Breast

Triple Negative Breast Neoplasms

NCT03298893 2025-09-19

NiCOL

Phase 1/2 Completed

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04383743 2025-09-18

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Phase 2 Completed

17 enrolled 12 charts

Genitourinary

Urinary Bladder Neoplasms

NCT04356170 2025-09-02

TPFmORL

Phase 2 Completed

105 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05880082 2025-08-24

PPIO-004-EC001

Phase 2 Completed

118 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03579771 2025-08-15

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Phase 2 Completed

30 enrolled 13 charts

Gastrointestinal

Cholangiocarcinoma

NCT01261728 2025-08-08

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

Phase 2 Completed

57 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT00665392 2025-08-01

ECHO-07

Phase 2 Completed

42 enrolled 24 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT05156970 2025-07-31

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Phase 2 Completed

81 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03086681 2025-07-29

ECWHCCFLACC

Phase 2 Completed

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02885974 2025-07-28

BLAST

Phase 1 Completed

22 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT03797625 2025-07-23

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

Phase 2 Completed

52 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03984357 2025-07-17

PLATINUM

Phase 2 Completed

152 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00199758 2025-07-16

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

Phase 2 Completed

227 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Phase 2 Completed

9 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Clinical Trials

Therapy for Children With Advanced Stage Neuroblastoma

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

ATEZOLACC

A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC

Auto-LLC 2001

Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

DARTBOARD

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

BDH-MCL01

Intratumoral Cisplatin for Resectable NSCLC

Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer

MesoPDT

ARCADIAN

DREAM3R

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

LyMa101

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)

Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

CETUXICOL

PINBALL

UPFRONT-NECK

A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

Pembrolizumab in Combination With CRT for LA-SCCHN

AACER

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

NiCOL

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

TPFmORL

PPIO-004-EC001

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma

ECHO-07

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

ECWHCCFLACC

BLAST

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

PLATINUM

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma